Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
6,770 total articles
argenx announced FDA approval for label expansion of VYVGART and VYVGART Hytrulo to treat all serotypes of adult patients living with generalized myasthenia gravis (gMG), including rare antibody-negative subtypes. The approval is based on positive Phase 3 ADAPT SERON study results showing rapid, significant, and sustained symptom improvement with a…
DSS, Inc. announced that its 2025 annual report (10-K) contains a "going concern" audit qualification by HTL International LLC, indicating significant doubts about the company's ability to continue operations. The disclosure complies with NYSE American regulations and does not alter the financial statements themselves. DSS operates diverse business…
Shreya Acquisition Group, a newly formed special purpose acquisition company (SPAC), has closed its $110 million initial public offering, including partial exercise of its over-allotment option. The units began trading on the NYSE under the ticker SAGUU. The company plans to pursue a business combination with companies primarily in health and welln…
Cornerstone Strategic Investment Fund, Inc. (CLM) and Cornerstone Total Return Fund, Inc. (CRF) announced their continuing monthly distributions through September 2026, maintaining their previously adopted monthly distribution policies. These distributions may include net earnings, capital gains, or return-of-capital, with return-of-capital expecte…
NVIDIA announced the appointment of Suzanne Nora Johnson, former Vice Chairman of Goldman Sachs and current Pfizer board member, to its board of directors effective July 13, 2026. Johnson will join the Audit Committee, expanding the board to 11 members. Her extensive experience spans finance, technology, and healthcare, providing valuable oversight…
Trump Media and Technology Group Corp. reported Q1 2026 results showing total assets of $2.2 billion and over $2 billion in financial assets, nearly tripling from the previous year. The company achieved its fourth consecutive quarter of positive operating cash flow, generating $17.9 million, despite a net loss primarily attributed to non-cash items…
MiNK Therapeutics will report its Q1 2026 financial results on May 15, 2026, accompanied by a corporate update showcasing advancements in its allogeneic invariant natural killer T (iNKT) cell therapy platform. The company emphasized progress in its lead candidate agenT-797 for cancer and immune disorders, highlighted recent scientific findings, and…
WeRide Inc., a leading autonomous driving technology company and the first publicly traded robotaxi operator, announced its Annual General Meeting (AGM) for June 26, 2026. The company aims to consider proposed shareholder resolutions, supported by its board, and has filed its annual report with the SEC. WeRide operates autonomous vehicles across mu…
ParaZero Technologies Ltd., an aerospace defense company listed on Nasdaq under the ticker PRZO, announced it has received a notification from Nasdaq indicating non-compliance with the minimum bid price requirement of $1.00 per share. The company has been granted 180 days until November 2, 2026, to regain compliance by achieving a closing bid price…
Fulcrum Therapeutics granted non-statutory stock options to two new employees as an inducement to their employment under Nasdaq Listing Rule 5635(c)(4). The options cover 55,500 shares at an exercise price equal to the closing stock price on May 4, 2026, vesting over four years with a ten-year term.
High Roller Technologies, a publicly traded online gaming and prediction markets company, announced a conference call scheduled for May 12, 2026, to provide a business update and discuss its Q1 2026 financial results. The company will also discuss key corporate developments including the planned launch of its prediction markets platform, signaling …
NI Holdings, Inc. reported its Q1 2026 financial results showing a 15.1% decline in gross premiums written to $57.5 million, primarily due to the strategic exit from the Non-Standard Auto segment. The company improved its combined ratio significantly to 79.7% reflecting strong underwriting across core segments, and net income nearly doubled to $12.…
ICZOOM Group Inc., a Nasdaq-listed B2B electronic components e-commerce platform, announced the postponement of its Extraordinary General Meeting from May 29, 2026, to August 31, 2026. The change allows the company to allocate adequate resources to prepare its interim financial statements. The record date for shareholder voting eligibility is adjus…
KULR Technology Group, a US-based energy-systems platform company specializing in ultra-high-power lithium battery safety solutions, plans to release its Q1 2026 financial results and host a conference call on May 14, 2026. Management will discuss the quarterly performance and answer shareholder questions submitted in advance.
Okeanis Eco Tankers Corp. will release its unaudited Q1 2026 financial results after the NYSE market closes on May 13, 2026, followed by a webcast on May 14, 2026. The company operates a modern fleet of scrubber-fitted tankers and is listed on both the NYSE and Oslo Stock Exchange.
Motorsport Games Inc., a developer and publisher of official motorsport racing video games and esports ecosystems, will report its Q1 2026 financial results on May 13, 2026, followed by a management conference call and webcast. The company continues to develop and maintain leading racing simulation platforms and esports events linked to prominent m…
Nyxoah SA invites its shareholders to attend the annual and extraordinary shareholders' meetings on June 10, 2026. The agenda includes approval of 2025 financial statements, discharge of directors and auditor, reappointment of board members, approval of remuneration report, ratification of bond instrument clauses related to convertible bonds, and r…
TOMI Environmental Solutions, a leader in disinfection technology, reported a 5% year-over-year revenue increase for Q1 2026, driven by strong equipment and customized system sales. The company announced a non-binding letter of intent to merge with Carbonium Core, a U.S. nuclear-grade graphite producer valued at $120 million. This merger aims to di…
Longeveron Inc. announced that a recent Type C meeting with the FDA resulted in constructive dialogue regarding the ongoing ELPIS II Phase 2b clinical trial of laromestrocel for Hypoplastic Left Heart Syndrome (HLHS). The FDA questioned the current primary endpoint of right ventricle ejection fraction as insufficient for demonstrating efficacy and …
Kandi Technologies Group, Inc. announced it received a Nasdaq notification regarding non-compliance with the minimum $1.00 bid price requirement for its shares on the Nasdaq Global Select Market. The deficiency period lasted from March 23, 2026, through May 4, 2026. Kandi has 180 calendar days to regain compliance before potentially moving to Nasda…
Femasys Inc. announced financial results for Q1 2026, showing a 24.5% increase in sales primarily driven by FemBloc. The company advanced commercialization of fertility products, initiated a pivotal clinical trial for its non-surgical permanent birth control FemBloc, and expanded strategic partnerships internationally. Operational improvements and …
Tenax Therapeutics announced the grant of inducement stock options totaling 657,500 shares to four newly hired non-executive employees in various clinical and commercial roles. The grants are made outside of the company's existing equity incentive plan, in accordance with Nasdaq listing rules, to attract and retain key personnel as the company adva…
Dynagas LNG Partners LP announced a quarterly cash distribution of $0.050 per common unit for the quarter ended March 31, 2026, payable on May 22, 2026. The partnership owns and operates six LNG carriers on multi-year charters with a total capacity of approximately 914,000 cubic meters.
Entera Bio Ltd. announced its financial results for Q1 2026 along with significant progress in its oral peptide drug development programs. The company submitted a streamlined Phase 3 protocol for EB613, an oral anabolic tablet for osteoporosis, to the FDA and completed a bridging study for its single-tablet formulation. It expanded its collaboratio…
Arcutis Biotherapeutics announced the grant of 269,000 restricted stock units and options for 70,000 shares to 40 newly hired employees under its 2022 Inducement Plan. These equity awards are designed to attract and retain talent, with vesting schedules spanning four years. The stock options have a ten-year term and an exercise price equal to the c…
